Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases

International Journal of Radiation Oncology, Biology, Physics
Ugur SelekMoshe H Maor

Abstract

To report on the outcome of patients with melanoma brain metastases treated with stereotactic radiosurgery (SRS). One hundred three patients with 153 intracranial melanoma metastases consecutively underwent Linac-based SRS between November 1991 and October 2001. The Kaplan-Meier method, univariate comparisons with log-rank test, and multivariate analyses with classification and regression tree models were performed. Calculations were based on last imaging date rather than the date of the last visit. Median age was 51 years (range, 18-93 years). Median Karnofsky performance status was 90. Sixty-one patients (59%) had single brain metastasis at presentation. Treatment sequence was SRS alone (61 patients), SRS + whole-brain radiotherapy (WBRT) (12 patients), and salvage SRS after WBRT (30 patients). The median tumor volume was 1.9 cm(3) (range, 0.06-22.3 cm(3)). The median SRS minimum peripheral dose and isodose was 18 Gy (range, 10-24 Gy) and 85% (range, 60%-100%), respectively. The median follow-up was 6 months for all patients and 13 months (range, 2-46 months) for patients alive at the time of analysis. The 1-year local control (LC) for all patients treated with SRS was 49%. Among the patients treated with initial SRS alone, t...Continue Reading

References

Jan 1, 1981·Neurosurgery·D E BullardH F Seigler
Jan 1, 1994·British Journal of Neurosurgery·P DaveyP W Cooper
Apr 1, 1996·International Journal of Radiation Oncology, Biology, Physics·R M AuchterM P Mehta
Nov 7, 1998·International Journal of Radiation Oncology, Biology, Physics·Y MoriL D Lunsford
Feb 13, 2001·International Journal of Radiation Oncology, Biology, Physics·J EllerhorstI McCutcheon
Aug 22, 2002·Neurosurgery·Paul D BrownRobert L Foote
Aug 2, 2003·Stereotactic and Functional Neurosurgery·Georges NoëlJean-Jacques Mazeron

❮ Previous
Next ❯

Citations

Nov 2, 2011·Cancer Chemotherapy and Pharmacology·Athanassios P KyritsisVictor A Levin
Sep 1, 2005·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Henrike WuestemeyerGerasimos Anastassiou
Feb 24, 2005·Neurosurgical Review·R Deinsberger, J Tidstrand
May 22, 2010·Neurosurgical Review·Nikolay A PeevHirotoshi Sano
Mar 19, 2013·Current Treatment Options in Oncology·Sarah NicholasMichael Lim
Aug 21, 2007·Current Oncology Reports·Martin Majer, Wolfram E Samlowski
Aug 21, 2013·Current Oncology Reports·Vikram GorantlaHussein A Tawbi
Sep 4, 2010·Medical Oncology·Simon S LoThomas E Olencki
Aug 3, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Xiujun ChenJianrong Dai
May 7, 2013·Clinical Neurology and Neurosurgery·Dorothea MillerIbrahim Erol Sandalcioglu
Jan 6, 2006·The Cancer Journal·Loren K Mell, Arno J Mundt
Oct 15, 2005·Current Opinion in Oncology·Juan J Martin, Douglas Kondziolka
Aug 3, 2005·American Journal of Clinical Oncology·Lisa J HazardDennis C Shrieve
Feb 9, 2012·International Journal of Surgical Oncology·William A HallHui-Kuo G Shu
Mar 6, 2009·Radiation Oncology·Carsten Nieder, Minesh P Mehta
Nov 27, 2007·Journal of Medical Case Reports·Astrid DalhaugCarsten Nieder
Jun 8, 2010·Journal of Neurosurgery·Donald N LiewL Dade Lunsford
Apr 12, 2011·Journal of Neurosurgery·Russell R LonserSteven A Rosenberg
Jul 5, 2007·Neurosurgical Focus·Moksha G Ranasinghe, Jonas M Sheehan
Jul 5, 2007·Neurosurgical Focus·Michael L Smith, John Y K Lee
Dec 27, 2013·Case Reports in Gastrointestinal Medicine·Satya Allaparthi, Khalid A Alkimawi
Jan 15, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Marcello MarchettiLaura Fariselli
Jul 7, 2011·World Journal of Surgical Oncology·Ameer L ElaimyChristopher M Lee
Nov 4, 2011·Clinical Neurology and Neurosurgery·Melike Mut
Aug 27, 2011·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Timothy L SiuJohn W Fuller
Apr 15, 2011·International Journal of Radiation Oncology, Biology, Physics·Niloufer KhanRoger Macklis
Sep 8, 2016·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Jadwiga Nowak-SadzikowskaMarian Reinfuss
Aug 24, 2010·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·J R MarsdenUNKNOWN British Association of Dermatologists (BAD) Clinical Standards Unit
Jul 22, 2009·International Journal of Radiation Oncology, Biology, Physics·James L FrazierDaniele Rigamonti
Mar 4, 2008·International Journal of Radiation Oncology, Biology, Physics·Eduardo Weltman, Reynaldo André Brandt
Jun 15, 2007·Seminars in Oncology·Andrew A KannerZvi Ram
Jul 9, 2010·The British Journal of Dermatology·J R MarsdenUNKNOWN British Association of Dermatologists Clinical Standards Unit
Dec 10, 2013·Acta Neurologica Scandinavica·S G RogneT R Meling
Feb 28, 2016·World Neurosurgery·Yazan AbuodehHsiang-Hsuan Michael Yu
May 12, 2012·International Journal of Surgical Oncology·Angela HongMichael A Izard
May 10, 2006·International Journal of Radiation Oncology, Biology, Physics·Caroline Gaudy-MarquesteJean-Jacques Grob
Aug 4, 2015·Journal of Neuro-oncology·Andrew YaehTony J C Wang
Sep 24, 2015·Surgical Neurology International·Sebastian M ChristEkkehard M Kasper
Feb 8, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Maria J SambadeJaniel M Shields

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.